Betaine for syringomyelia when other treatments failed
Part of Brain & nervous system clinical trials.
This trial tests if betaine can help people with syringomyelia who cannot have or did not benefit from standard surgery. You must be able to swallow tablets and have a life expectancy over 12 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You cannot have or did not get better from surgery to open the covering of the spinal cord (duraplasty) or place a shunt within the past year.
- Your life expectancy is more than 12 months.
- You are able to swallow tablets.
- You or a constant caregiver can understand and sign a consent form.
- You do not have heart disease, severe infection, active tuberculosis, HIV, or other serious medical conditions listed in the exclusion criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the drug thalidomide can help people with syringomyelia (a fluid-filled cyst in the spinal cord) who cannot have standard surgery or for whom surgery didn't work. It aims to see if thalidomide can slow or improve symptoms.
This trial tests two surgical options for people with a spinal cord injury or infection that caused a fluid-filled cavity (syrinx) in the spine. It compares a new type of bypass surgery with a procedure to remove scar tissue, to see which helps improve symptoms better.
This trial tests if a medicine called cilostazol can reduce the risk of a delayed shortage of blood in the brain after having a bleeding aneurysm treated. It aims to improve recovery by preventing a common complication called delayed cerebral ischemia.
This study tests whether a medication called galantamine can help improve metabolic syndrome (a cluster of health conditions including obesity, high blood sugar, and high cholesterol) in people with chronic spinal cord injury. The goal is to see if this treatment can reduce health risks and improve overall wellness.
This trial tests whether mexiletine hydrochloride can help men with spinal and bulbar muscular atrophy (SBMA) by improving muscle strength and function. It may be an option if you have mild to moderate symptoms and meet heart and medication safety checks.
This trial tests a new drug, SYHA1813, for people whose high-grade meningioma has come back or gotten worse after standard treatments like surgery and radiation. The goal is to see if this drug can help control the tumor and improve outcomes.
Hear when a new Syringomyelia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.